LAZARD ASSET MANAGEMENT LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,033
-9.1%
6,500,0000.0%0.01%0.0%
Q2 2023$4,436
-61.9%
6,500,000
-56.7%
0.01%
-66.7%
Q1 2023$11,628
-33.4%
15,000,000
-34.8%
0.02%
-37.5%
Q4 2022$17,453
-99.9%
23,000,000
+1.6%
0.02%
-11.1%
Q3 2022$18,285,000
+42.1%
22,627,000
+29.3%
0.03%
+58.8%
Q2 2022$12,872,000
-41.3%
17,500,000
-32.4%
0.02%
-32.0%
Q1 2022$21,935,000
+19.3%
25,890,000
+15.1%
0.02%
+25.0%
Q4 2021$18,393,000
+25.3%
22,500,000
+15.4%
0.02%
+17.6%
Q3 2021$14,675,000
-16.4%
19,500,000
+11.4%
0.02%
-15.0%
Q2 2021$17,552,000
-24.7%
17,500,000
-22.2%
0.02%
-28.6%
Q1 2021$23,319,000
+12.2%
22,500,000
+36.4%
0.03%
+7.7%
Q4 2020$20,780,000
+24.1%
16,500,000
+17.9%
0.03%
+8.3%
Q3 2020$16,739,000
-8.1%
14,000,000
+7.7%
0.02%
-14.3%
Q2 2020$18,219,000
+5.9%
13,000,000
+8.3%
0.03%
-12.5%
Q1 2020$17,196,000
+50.4%
12,000,000
+50.0%
0.03%
+100.0%
Q4 2019$11,435,0008,000,0000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 20,000,000$25,176,0001.70%
DeepCurrents Investment Group LLC 22,530,000$28,226,0000.74%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 20,000,000$24,888,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 35,000,000$43,527,0000.26%
AQR Arbitrage LLC 4,100,000$5,164,0000.18%
CSS LLC/IL 3,000,000$3,781,0000.14%
Verition Fund Management LLC 6,579,000$8,286,0000.07%
LAZARD ASSET MANAGEMENT LLC 16,500,000$20,780,0000.03%
Citadel Advisors 43,300,000$54,252,0000.01%
CREDIT SUISSE AG/ 5,017,000$6,243,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders